Adisbel Espinosa Ramirez is a Miami, Florida based nurse practitioner. Active license number of Adisbel Espinosa Ramirez is 11026928 in Florida. Her current practice location is 12252 Sw 221st St Rd, Miami. Patients can reach her at 786-659-7306. Adisbel Espinosa Ramirez is ARNP and her NPI number (Unique professional ID assigned by NPPES) is 1144906033. Adisbel Espinosa Ramirez has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Adisbel Espinosa Ramirez speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1144906033
NPI Enumeration Date:
26 Jun, 2023
NPI Last Update On:
26 Jun, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Adisbel Espinosa Ramirez are as mentioned below.
License Number
Specialization
State
Status
11026928
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Adisbel Espinosa Ramirez 12252 Sw 221st St Rd, Miami, Florida
Zip:
33170-4656
Phone Number:
786-659-7306
Patients can reach Adisbel Espinosa Ramirez at 12252 Sw 221st St Rd, Miami, Florida or can call to book an appointment on 786-659-7306.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.